Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
Fisher
Galen H
GH
Lang
Pearon G
PG
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005153:Facial Neoplasms / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D000077271:Imiquimod; D008545:Melanoma / Q000473:pathology; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009381:Neoplasms, Radiation-Induced / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod